Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy

• Status: Terminated
• Trial end date: 2020-01-26
• Target enrollment: 0
• Participant gender: All

Summary

This a study aiming to compare treatment with tamsulosin versus placebo in patients undergoing endoscopic treatment for urolithiasis. The main outcome is the rate of stone free patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pontificia Universidad Catolica de Chile
• Treatments: Tamsulosin

Criteria

Inclusion Criteria:

• Patients with urolithiasis undergoing to endoscopic ureterolithotomy

Exclusion Criteria:

• Patients with previous ureteral catheter

• Patients with allergy to tamsulosin

• Patients currently in treatment with tamsulosin for other disease different than ureterolithiasis

• Multiple ureterolithiasis

• Patients with impairment of their mental status

• Patients with open surgeries in the affected ureter or urinary diversion

• Pregnancy